Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Accuray Shares Rise on Q2 Earnings, Increased Backlog and Raised FY/20 EBITDA Guidance

Shares of Accuray traded 15% higher today after the company reported Q2/20 financial results. Late yesterday afternoon, radiation oncology company Accuray Inc. (ARAY:NASDAQ) , which develops, manufactures and markets radiotherapy systems used in cancer trea...
Streetwise Reports | January 30, 2020 |

New Century Resources, Alcidion Group, Telix Pharmaceutical, Marley Spoon - emerging ASX companies

The Australian stock exchange, which is based in Sydney, has been called the Australian Securities Exchange (ASX) since 2006. Since 1987, the trading place for securities has been located at this central location. Previously, the business with investments in various cities was...
Mario Hose | May 27, 2020 |

Buzz on the Bullboards: From innovating traffic enforcement to cancer breakthroughs

The past week on the TSX has been one for the books, with significant gains driven largely by advancements in the technology sector. The S&P 500 and NASDAQ have hit fresh highs, a clear sign of a hungry market bolstered by technology stocks. This momentum has put a spot...
Jonathon Brown | June 20, 2024 |

Medicus Pharma advances cancer treatment towards phase II trial

The following is a transcription of the above video, and The Market Herald Canada has edited it for clarity . Our next company is Medicus Pharma Ltd. (TSXV:MDCX) , headquartered in Philadelphia, Pennsylvania. The company is a publicly traded clinical stage, multi-st...
Ryan Dhillon | January 22, 2024 |

Theralase is raising up to $5.3M to complete bladder cancer study

Theralase Technologies is announcing a brokered financing raise for up to C$5.3 million Proceeds of the financing will be used to further the Phase II Non-Muscle Invasive Bladder Cancer (NMIBC) clinical study Ruvidar is designed to destroy solid core tum...
Coreena Robertson | November 6, 2023 |

Buzz on the Bullboards: Whose stocks sizzle during summer holidays?

As we get through the summer holiday season, the typically calmer market environment presents a prime opportunity for investors to evaluate their portfolios and consider new investments. The TSX continues to offer a variety of promising stocks, particularly in energ...
Jonathon Brown | July 4, 2024 |

Does this Device Solve the Issue of Electromagnetic Radiation?

There is a large health issue that few know about and does not see much press, but it is there for everyone to see buried in the fine print when you buy most cell phones. I am talking about electromagnetic radiation (EMR) that is emitted with electronic devices, such as...
Streetwise Reports | January 7, 2020 |

A potential breakthrough in spinal cord and optic nerve injury treatment

Click Here to Download the Full Report This is third-party provided content issued on behalf of NurExone Biologic Inc., please see full disclaimer here .
Research | December 19, 2024 |

Revolutionizing Mental Health Treatment

(Click to play video.) Cybin Inc. ( NEO: CYBN , NYSE: CYBN , Forum ) is a Toronto-based life sciences company initially focused on psychedelic pharmaceutical therapies supporting research to advance psychedelic therapies centered on improving mental health and...
Featured Submission | August 13, 2021 |

Microbot Shares Soar ...

Microbot Shares Soar on Claims It Has Created the World's First Fully Disposable Endovascular Robotic System Shares of Microbot Medical traded 70% higher after the company reported that in January 2020 it will unveil the world's first fully disposable robotic system fo...
Streetwise Reports | December 27, 2019 |
1 2 3 4 5 6 7 8 9 10 ...